Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Preliminary phase I data on the efficacy of TA-NIC in nicotine addiction

March 7, 2005

Dopamine transporter ligand identified with potential efficacy as a treatment for cocaine addiction

March 3, 2005

Evidence supports the use of nicotine replacement therapies in heavy smokers

March 2, 2005

Somaxon licenses rights for oral nalmefene for nicotine dependence

Feb. 28, 2005

Efficacy of the GABA-B receptor agonist CGP-44532 in response to nicotine

Feb. 16, 2005

Subutex approved in Canada for opiate addiction treatment

Feb. 15, 2005

Neuropeptide Y Y2 antagonist effective in rats with ethanol dependence

Feb. 14, 2005

RiVax ricin vaccine enters clinical testing

Feb. 9, 2005

SR-147778: further evidence that CB1 antagonism may be effective for the treatment of alcoholism

Feb. 8, 2005

New varenicline formulations for smoking cessation reported by Pfizer

Feb. 4, 2005

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...